Food and Behaviour Research

Donate Log In

12 November 2014 - Nutritional Outlook - EU Is One Step Closer to DHA, Brain Development Article 14 Claim

The EU is getting closer to an Article 14 health claim linking DHA omega-3 consumption and normal brain development—especially in children.

On October 8, the European Food Safety Authority (EFSA) responded positively to an Article 14 health claim petition that “DHA contributes to normal brain development." Ingredient supplier DSM Nutritional Products (Parsippany, NJ) submitted the petition.

“The Panel considers that DHA is sufficiently characterised, and that contribution to normal brain development is a beneficial physiological effect for infants and children,” EFSA stated.

To bear the claim, foods for children aged 6 to 24 months must provide a daily intake of 100 mg of DHA over the course of one or multiple servings. Foods for children aged 2 to 18 years must provide a daily intake of 250 mg of DHA within one or more servings.

Article 14 health claims refer to the reduction of disease risk or to children's development or health. Other Article 14 health claims for DHA already approved in the EU include those for normal vision development in infants up to 12 months old and for maternal intake for normal vision and brain development in fetuses and breastfed infants.